Omeat
Mohammad Ali Gholampour is a Research Scientist at Omeat with a background in conducting research on immune cells and stem cells. Previously, Mohammad Ali worked as a Postdoctoral Scholar at the University of California, San Francisco, where Mohammad Ali focused on collagen uptake in immune cells using genetically engineered mouse models. Mohammad Ali also completed their Ph.D. in Hematology at Tarbiat Modares University, where Mohammad Ali studied the effects of MSC-exosomes on T cell cytokine release and proliferation. Additionally, Mohammad Ali holds a Master's degree in Hematology and a Bachelor's degree in Clinical Laboratory Science/Medical Technology/Technologist.
This person is not in the org chart
This person is not in any teams
Omeat
Omeat is a food startup that has pioneered a scalable way to produce cultivated meat that’s delicious, affordable, orders-of-magnitude more sustainable than conventional meat, and doesn’t involve sacrificing an animal. The secret to Omeat is a proprietary process that harnesses the intrinsically regenerative factors within cows' plasma to foster cell growth. Omeat’s growth media is a cost-effective alternative to fetal bovine serum and can be used to cultivate any kind of meat. Omeat is based in Los Angeles, founded in 2020 by world-renown tissue biologist Dr. Ali Khademhosseini. The company is currently building a pilot plant and rapidly expanding its team toward commercial readiness.